Pages that link to "Q46126412"

The following pages link to Serum advanced glycation end products (AGEs) are associated with insulin resistance (Q46126412):

Displaying 39 items.

• Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS? (Q26774333) (← links)
• Relationship between Advanced Glycation End Products and Steroidogenesis in PCOS (Q28077960) (← links)
• Effects of Two Different Dietary Patterns on Inflammatory Markers, Advanced Glycation End Products and Lipids in Subjects without Type 2 Diabetes: A Randomised Crossover Study (Q33616622) (← links)
• RAGE regulates the metabolic and inflammatory response to high-fat feeding in mice (Q33646761) (← links)
• Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial. (Q33904838) (← links)
• Determinants of concentrations of N(ε)-carboxymethyl-lysine and soluble receptor for advanced glycation end products and their associations with risk of pancreatic cancer (Q34426525) (← links)
• Advanced glycation end products in infant formulas do not contribute to insulin resistance associated with their consumption (Q34542291) (← links)
• Novel CoQ10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, Tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats (Q35106778) (← links)
• Accumulation of advanced glycation end-products and activation of the SCAP/SREBP Lipogenetic pathway occur in diet-induced obese mouse skeletal muscle (Q35159141) (← links)
• Diabetes and cancer: Looking at the multiligand/RAGE axis. (Q35172873) (← links)
• Advanced glycation end products and oxidative stress in type 2 diabetes mellitus (Q35255473) (← links)
• Association between Advanced Glycation End Products and Impaired Fasting Glucose: Results from the SALIA Study (Q35644178) (← links)
• Antidiabetic effect of green rooibos (Aspalathus linearis) extract in cultured cells and type 2 diabetic model KK-A(y) mice (Q35761910) (← links)
• Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women (Q36047141) (← links)
• Glycation and insulin resistance: novel mechanisms and unique targets? (Q36115715) (← links)
• Insulin resistance: metabolic mechanisms and consequences in the heart. (Q36821424) (← links)
• Carbonyl stress in aging process: role of vitamins and phytochemicals as redox regulators (Q37225026) (← links)
• Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect. (Q37382495) (← links)
• Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice (Q38319272) (← links)
• Effect of diet-derived advanced glycation end products on inflammation. (Q38588208) (← links)
• Calycosin Rebalances Advanced Glycation End Products-Induced Glucose Uptake Dysfunction of Hepatocyte In Vitro (Q38829652) (← links)
• Mechanisms for antidiabetic effect of gingerol in cultured cells and obese diabetic model mice (Q38998683) (← links)
• High Serum Advanced Glycation End Products Are Associated with Decreased Insulin Secretion in Patients with Type 2 Diabetes: A Brief Report. (Q41037085) (← links)
• Protein Biomarkers for Insulin Resistance and Type 2 Diabetes Risk in Two Large Community Cohorts (Q41287831) (← links)
• The Contribution of Singlet Oxygen to Insulin Resistance. (Q42730512) (← links)
• Association of the glycoxidative stress marker pentosidine with equine laminitis. (Q45004079) (← links)
• Serum advanced glycation end products are associated with insulin resistance in male nondiabetic patients with obstructive sleep apnea (Q48003122) (← links)
• Obesity induced alterations in redox homeostasis and oxidative stress are present from an early age. (Q48165451) (← links)
• Disparity in the micronutrient content of diets high or low in advanced glycation end products (AGEs) does not explain changes in insulin sensitivity. (Q51825509) (← links)
• Visualization of methylglyoxal in living cells and diabetic mice model with a 1,8-naphthalimide-based two-photon fluorescent probe (Q57496161) (← links)
• Sex differences of oxidative stress markers in young healthy subjects are marker-specific in plasma but not in saliva (Q57825924) (← links)
• Multifaceted Interweaving Between Extracellular Matrix, Insulin Resistance, and Skeletal Muscle (Q58702059) (← links)
• The non-saponin fraction of Korean Red Ginseng (KGC05P0) decreases glucose uptake and transport in vitro and modulates glucose production via down-regulation of the PI3K/AKT pathway in vivo (Q90147258) (← links)
• Protective effect of hydrogen sulfide on oxidative stress-induced neurodegenerative diseases (Q90272863) (← links)
• The Protective Effect of Brazilian Propolis against Glycation Stress in Mouse Skeletal Muscle (Q90311373) (← links)
• Addressing Stem Cell Therapeutic Approaches in Pathobiology of Diabetes and Its Complications (Q90479839) (← links)
• Advanced Glycation End Products of Bovine Serum Albumin Suppressed Th1/Th2 Cytokine but Enhanced Monocyte IL-6 Gene Expression via MAPK-ERK and MyD88 Transduced NF-κB p50 Signaling Pathways (Q91658602) (← links)
• Endothelial Dysfunction and Advanced Glycation End Products in Patients with Newly Diagnosed Versus Established Diabetes: From the CORDIOPREV Study (Q92810756) (← links)
• Psoralea corylifolia L. Seed Extract Attenuates Methylglyoxal-Induced Insulin Resistance by Inhibition of Advanced Glycation End Product Formation (Q92898790) (← links)